Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)

Clinical trial NCT07265570 · RECRUITING

Trial details

NCT number: NCT07265570
Sponsor: InSilico Medicine Hong Kong Limited
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2025-12-10
Primary completion: 2027-08-15
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.